Literature DB >> 12127367

QT dispersion in patients with different etiologies of left ventricular hypertrophy: the significance of QT dispersion in endurance athletes.

Mehdi Zoghi1, Cemil Gürgün, Oguz Yavuzgil, Azem Akilli, Cüneyt Türkoglu, Hakan Kültürsay, Mustafa Akin.   

Abstract

Left ventricular hypertrophy (LVH) increases the risk of ventricular arrhythmias and sudden death and has a significant effect on total cardiovascular mortality. QT dispersion (QTd) is a measure of inhomogeneous repolarization and is used as an indicator of arrhythmogenicity. In this study we detected QTd in patients with different etiologies of left ventricular hypertrophy and the effect of LVH in QTd on endurance athletes. The study group consisted of 147 white male subjects with 3 different etiologies of LVH and 30 healthy male individuals. The underlying etiologies of LVH were essential hypertension, valvular aortic stenosis and long-term training (athletic heart). QTd was measured by surface electrocardiogram and Bazett's formula was used to correct QTd for heart rate (QTcd). Left ventricular mass was determined by transthoracic echocardiography and left ventricular mass index was calculated in relation to body surface area. The QTcd was significantly higher in patients with pathological LVH (due to hypertension and aortic stenosis) than in the athletes' group (physiological LVH) and healthy subjects (P<0.05). The magnitude of QTcd was similar between athletes and the control group (P=0.6). The difference of QTcd between the groups with pathological LVH was not statistically significant (P=0.1). In conclusion; the increasing of QT dispersion is associated with only pathological conditions of LVH. The left ventricular hypertrophy has not a negative effect in QT dispersion on endurance athletes. The measurement of QT dispersion may be a non-invasive useful method for screening additional pathological conditions in endurance athletes.

Entities:  

Mesh:

Year:  2002        PMID: 12127367     DOI: 10.1016/s0167-5273(02)00140-7

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

Review 1.  Is the 'athlete's heart' arrhythmogenic? Implications for sudden cardiac death.

Authors:  Thomas Rowland
Journal:  Sports Med       Date:  2011-05-01       Impact factor: 11.136

Review 2.  Modulation of the QT interval duration in hypertension with antihypertensive treatment.

Authors:  Jan Klimas; Peter Kruzliak; Simon W Rabkin
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

3.  The Effect of Chronic Anabolic-Androgenic Steroid Use on Tp-E Interval, Tp-E/Qt Ratio, and Tp-E/Qtc Ratio in Male Bodybuilders.

Authors:  Elnur Alizade; Anıl Avcı; Serdar Fidan; Mustafa Tabakçı; Mustafa Bulut; Regayip Zehir; Zeki Simsek; Mert Evlice; Uğur Arslantaş; Hakan Çakır; Mehmet Yunus Emiroglu; Mustafa Akçakoyun
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-01-28       Impact factor: 1.468

4.  Electrocardiographic signs of left ventricular hypertrophy in obese patients: what criteria should be used?

Authors:  Giuseppe Germano
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-08-05

5.  Exercise-induced arterial hypertension - an independent factor for hypertrophy and a ticking clock for cardiac fatigue or atrial fibrillation in athletes?

Authors:  Roman Leischik; Norman Spelsberg; Hiltrud Niggemann; Birgit Dworrak; Klaus Tiroch
Journal:  F1000Res       Date:  2014-05-12

6.  Defective recovery of QT dispersion following transcatheter aortic valve implantation: frequency, predictors and prognosis.

Authors:  Rutger-Jan Nuis; Gokhan Turgut; Robert M van der Boon; Nicolas M van Mieghem; Sjoerd T Nauta; Patrick W Serruys; Ron T van Domburg; Giulio Zuchelli; Luc Jordaens; Peter P de Jaegere
Journal:  J Geriatr Cardiol       Date:  2015-09       Impact factor: 3.327

7.  A 24-hour ambulatory ecg monitoring in assessment of qt interval duration and dispersion in rowers with physiological myocardial hypertrophy.

Authors:  I Y Lutfullin; Z F Kim; R R Bilalova; N A Tsibulkin; R R Almetova; R R Mudarisova; I I Ahmetov
Journal:  Biol Sport       Date:  2013-11-25       Impact factor: 2.806

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.